Speaker: Dr. Deepak Natarajan was head of the Cardiology department of Ram Manohar Lohia Hospital, New Delhi, and Interventional Cardiology departments of several corporate hospitals. He has been cardiologist to the President of India

 

Chair: Prof. Khalilullah 

 

The talk shall underscore the evolution of anti-hypertensive drug treatment based upon controlled trials, and the current position of cardiac societies in the treatment of hypertension. Every third adult in India and more than a billion worldwide suffer from high blood pressure. Half a century of rigorous studies documenting treatment and prevention of heart attacks, strokes and death with drug therapy have however so far failed to identify the lowest goal that is both safe and effective